Skip to content

Meet the Team

Steering Committee

The work conducted by CF AMR Syndicate is overseen by a steering committee comprising people with CF, leading industry and academic experts in CF AMR, clinicians and representatives from the Medicines Discovery Catapult and Cystic Fibrosis Trust.

The steering committee is responsible for the development and delivery of the CF AMR Syndicate in AMR’s strategy. It provides on-going scientific advice and insights of people with CF on all Syndicate’s activities.


Dr Deborah O’Neil

Chief Executive Officer, NovaBiotics Ltd


Prof. Jane Davies
(Deputy Chair)

Professor in Paediatric Respirology & Experimental Medicine, National Heart and Lung Institute


Dr Richard Amison

Lecturer in Pharmacology, Scholl of Cancer and Pharmaceutical Science King’s College London


Prof. Miguel Camara

Professor of Molecular Microbiology, University of Nottingham & Co-Director, National Biofilm Innovations Centre


Dr. Victoria Savage

Head of Biology at Infex Therapeutics


Prof. Andres Floto

Professor of Respiratory Biology, University of Cambridge & Research Director at the Cambridge Centre for Lung Infection


Dr Jo Fothergill

Senior Lecturer Clinical Infection, Microbiology and Immunology, University of Liverpool


Abigail Halstead

People with CF


Dr Peter Jackson

Executive Director, Infex Therapeutics


Prof. Clive Page

Professor of Pharmacology, King’s College London & Director of the Sackler Institute of Pulmonary Pharmacology


Dr Mark Sutton

Scientific Leader, Public Health England


Laura Taylor

People with CF


Dr Christian​ Zwingelstein

Clinical Pharmacology, Antabio


Prof. Adilia Warris

Paediatric infectious disease specialist and Co-Director of the MRC Centre for Medical Mycology, University of Exeter

Pam Brown

Pam Brown

Head of Chemistry, Centauri Therapeutics

Dr Yoann Personne

Dr Yoann Personne

Director UK& Ireland Medical Affairs, bioMérieux

Management Team

The CF Syndicate in AMR is a partnership between Medicines Discovery Catapult and the Cystic Fibrosis Trust. Medicines Discovery Catapult (MDC) is a government-funded, not-for-profit organisation. It is enabling the community to reshape medicines discovery in the UK. The Trust is the only UK charity dedicated to fighting for a life unlimited by cystic fibrosis for everyone affected by the condition.

Day-to-day management of the Syndicate is carried out by:




Constance Takawira

Partnership Manager, Medicines Discovery Catapult


Dr Paula Sommer

Head of Research, Cystic Fibrosis Trust


Dr Beverley Isherwood

Partnership Lead, Medicines Discovery Catapult


Dr Lucy

Director of Research, Cystic Fibrosis Trust


Dr Catherine Kettleborough

Translational Challenge Leader – Associate Director, Drug Discovery Biology, LifeArc


Dr Kevin Buchan

Business Development Manager, LifeArc

CF AMR Ed Roundel

Dr Ed McIver

Principal Scientist, LifeArc

CF AMR Neill Roundel V2

Dr Neill Gingles

Partnership Manager – CF AMR Syndicate

Contact CF AMR Syndicate

If you have a question that you can’t find the answer to or would
like to get involved with the Syndicate

If you have a question that you can’t find the answer to